You are here

PROsIT: A Total Patient-Reported Outcomes Solution

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43MH069169-01
Agency Tracking Number: MH069169
Amount: $107,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2003
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
CARACAL, INC. 221 N LA SALLE ST, STE 1108
CHICAGO, IL 60601
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 DERSHUNG YANG
 (847) 691-0494
 DYANG@CARACALINC.COM
Business Contact
Phone: (847) 691-0494
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): The PROslT Project seeks to promote the use of Patient-Reported Outcomes (PROs) in both clinical and research practices for AIDS by developing and commercializing a comprehensive, practical and integrated system for PROs management with cross-discipline efforts. It offers innovative solutions to user accessibility and item bank management issues. The specific Phase 1 aims are to: 1) develop the prototype of an Item Response Theory (IRT)-based adaptive PROs assessment engine supporting access from both web and phones; 2) elicit system requirements from both patients' and physicians' perspectives; and 3) identify potential system usage barriers in clinical settings. This study extends from our earlier work on computerized outcomes solutions for AIDS and cancers. The FAHI questionnaire will be used. Focus group discussions with physicians and patients and face-to-face interviews with pilot-testing participants will be conducted to evaluate system usability and usefulness, refine requirements, and identify potential barriers. PROslT is a generic outcomes collection, analysis and reporting solution applicable to AIDS and other diseases. It enables researchers to further understand the strengths and limitations of PROs in helping clinical decisions by reaching to a broader patient base. It also has wide-ranging applications for pharmaceutical companies, hospitals, insurers, and government agencies and accreditation organizations.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government